Cargando…
Mesenchymal stromal cells for sepsis and septic shock: Lessons for treatment of COVID‐19
Sepsis is defined as life‐threatening organ dysfunction caused by a deregulated immune host response to infection. The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has highlighted this multifactorial and complex syndrome. The absence of specific treatment neither aga...
Autores principales: | Laroye, Caroline, Gibot, Sébastien, Huselstein, Céline, Bensoussan, Danièle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461462/ https://www.ncbi.nlm.nih.gov/pubmed/32808462 http://dx.doi.org/10.1002/sctm.20-0239 |
Ejemplares similares
-
Clinical-grade mesenchymal stem cells derived from umbilical cord improve septic shock in pigs
por: Laroye, Caroline, et al.
Publicado: (2018) -
Bone marrow vs Wharton’s jelly mesenchymal stem cells in experimental sepsis: a comparative study
por: Laroye, Caroline, et al.
Publicado: (2019) -
Scale-Up of Academic Mesenchymal Stromal Cell Production
por: Laroye, Caroline, et al.
Publicado: (2023) -
Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton’s Jelly, an Extraembryonic Source
por: Laroye, Caroline, et al.
Publicado: (2019) -
How to improve the care of septic patients following “Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021”?
por: Hu, Baoji, et al.
Publicado: (2022)